Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma

NCT05806580 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Relapsed or Refractory B-cell Lymphoma

Interventions

DRUG: Relma-cel

Sponsor

Ruijin Hospital